In the five years since Canada legalized cannabis, the market has grown rapidly, with consumers now able to choose from a wide variety of strains and products. Among the most important purchasing criteria for many cannabis users is the level of THC, the psychoactive compound that produces the "high."
However, product labels may be misleading, often significantly overstating the THC potency of the product. This has been, and continues to be, a growing problem in Ontario—a problem that undermines consumer trust and threatens the legitimacy of the cannabis industry itself.
Cannabis testing laboratories, producers, and regulators have all sounded the alarm over inflated THC levels. Independent tests by laboratories, including a study from McMaster University, have shown that actual THC concentrations in cannabis products sold by the Ontario Cannabis Store are frequently lower than advertised. This is more than a mere technical discrepancy; it reflects a broader issue of misrepresentation in an industry that was supposed to be transparent and regulated for the public good. As with any other consumer product, accuracy in labeling is essential not only for trust but also for health and safety.
Read more at Q Briefing.